Rigel Pharmaceuticals (RIGL) Interest & Investment Income (2010 - 2026)
Rigel Pharmaceuticals (RIGL) recorded quarterly Interest & Investment Income of $1.2 million in Q1 2026, down 3.06% quarter-over-quarter from $1.2 million in Q4 2025, and up 103.89% on a YoY basis from $591000.0 in Q1 2025.
Rigel Pharmaceuticals (RIGL) Interest & Investment Income (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Interest & Investment Income history runs 17 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 103.89% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $4.3 million (up 105.5% YoY), while the FY2025 annual figure was $3.7 million, up 75.96% from the prior year.
- Interest & Investment Income was $1.2 million for Q1 2026 at Rigel Pharmaceuticals, down from $1.2 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.2 million in Q4 2025 to a low of $21000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $584352.9 across 5 years, with a median of $552000.0 in 2024.
- The sharpest annual moves came in 2022 and 2024: Interest & Investment Income jumped 2581.25% in 2022, then sank 36.76% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $429000.0 in 2022, then surged by 58.04% to $678000.0 in 2023, then dropped by 23.01% to $522000.0 in 2024, then surged by 138.12% to $1.2 million in 2025, then dropped by 3.06% to $1.2 million in 2026.
- The last three Interest & Investment Income figures came in at $1.2 million (Q1 2026), $1.2 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Rigel Pharmaceuticals | 603.18 Mn | 456.49 Mn | 54.21 Mn | 1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.21 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 753,000.00 |
| Mar 31, 2025 | 591,000.00 |
| Dec 31, 2024 | 522,000.00 |
| Sep 30, 2024 | 425,000.00 |
| Jun 30, 2024 | 552,000.00 |
| Mar 31, 2024 | 593,000.00 |
| Dec 31, 2023 | 678,000.00 |
| Sep 30, 2023 | 672,000.00 |
| Jun 30, 2023 | 529,000.00 |
| Mar 31, 2023 | 393,000.00 |
| Dec 31, 2022 | 429,000.00 |
| Sep 30, 2022 | 192,000.00 |
| Jun 30, 2022 | 42,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 16,000.00 |
| Sep 30, 2021 | 14,000.00 |
| Jun 30, 2021 | 16,000.00 |